Literature DB >> 4398340

Ocular toxin of the pneumococcus.

M K Johnson, J H Allen.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 4398340     DOI: 10.1016/0002-9394(71)91610-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  7 in total

1.  Host, microbial, and pharmacological factors affecting the outcome of suppurative keratitis.

Authors:  D J Coster; P R Badenoch
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

2.  Production and purification of Streptococcus pneumoniae hemolysin (pneumolysin).

Authors:  K Kanclerski; R Möllby
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

3.  Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae.

Authors:  J C Paton; R A Lock; D J Hansman
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

4.  Protection from Streptococcus pneumoniae keratitis by passive immunization with pneumolysin antiserum.

Authors:  Sherrina N Green; Melissa Sanders; Quincy C Moore; Erin W Norcross; Kathryn S Monds; Armando R Caballero; Larry S McDaniel; Sherrina A Robinson; Chinwendu Onwubiko; Richard J O'Callaghan; Mary E Marquart
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

5.  Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea.

Authors:  Mary E Marquart; Kathryn S Monds; Clare C McCormick; Sherrina N Dixon; Melissa E Sanders; Julian M Reed; Larry S McDaniel; Armando R Caballero; Richard J O'Callaghan
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-06       Impact factor: 4.799

Review 6.  Proteomics in the Study of Bacterial Keratitis.

Authors:  Rachida Bouhenni; Jeffrey Dunmire; Theresa Rowe; James Bates
Journal:  Proteomes       Date:  2015-12-14

7.  Infectious keratitis: secreted bacterial proteins that mediate corneal damage.

Authors:  Mary E Marquart; Richard J O'Callaghan
Journal:  J Ophthalmol       Date:  2013-01-08       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.